← All trials
NCT00277576
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2006
- Primary completion
- —
- Completion date
- Dec 1, 2007
- First posted
- —
- Last posted
- —
- Enrollment
- 48
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- PowderMedLead sponsor
- Singapore General HospitalOverall official - principal investigator
- Cathay General HospitalOverall official - principal investigator
- Siriraj HospitalOverall official - principal investigator
- The University of Hong KongOverall official - principal investigator
- National University of SingaporeOverall official - principal investigator
- Maharaj Nakorn Chiang Mai HospitalOverall official - principal investigator
- Chang Gung UniversityOverall official - principal investigator
- City University of Hong KongOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.